Product peptide-Inhibitory-peptide

Home > products > peptide> Inhibitory-peptide

Catalog	name	Description	price
R-R-0863	Cyclic somatostatin	Cyclic somatostatin (SRIF-14)/CAS.38916-34-6 is a growth hormone-release inhibiting factor used in the research of severe, acute hemorrhages of gastroduodenal ulcers. Cyclic somatostatin is a neuropeptide co-stored with acetylcholine in the cardiac parasympathetic innervation, exerts influences directly on contraction of ventricular cardiomyocytes. Cyclic somatostatin inhibits the contractile response of isoprenaline with an IC50 value of 13 nM. Cyclic somatostatin can be used for the research of cardiovascular disease.	price>
R-R-0866	Atosiban acetate	Atosiban acetate/CAS.914453-95-5 (RW22164 acetate;RWJ22164 acetate) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research.	price>
R-R-0869	Enfuvirtide acetate	Enfuvirtide acetate/CAS.914454-00-5 from ruixi. Enfuvirtide (T20; DP178) acetate is an anti-HIV-1 fusion inhibitor peptide.	price>
R-R-0870	NLS-StAx-h TFA	NLS-StAx-h TFA is a selective, cell permeable, stapled peptide Wnt signaling inhibitor with an IC50 of 1.4 μM. NLS-StAx-h TFA efficiently inhibits β-catenin-transcription factor interactions. NLS-StAx-h TFA shows anti-proliferation of cancer cells.	price>
R-R-0874	Edonerpic maleate	Edonerpic maleate/CAS.519187-97-4 is a novel neurotrophic agent which can inhibit amyloid-β peptides (Aβ).	price>
R-R-0876	hFSH-b-(33-53) (TFA)	hFSH-β-(33-53) TFA, a thiol-containing peptide which corresponds to a second FSH receptor-binding domain, is a FSHR (follicle-stimulating hormone receptor) antagonist. hFSH-β-(33-53) TFA inhibits binding of FSH to receptor and is a partial agonist of estradiol synthesis in Sertoli cells.	price>
R-R-0877	ERAP2-IN-1	ERAP2-IN-1/CAS.2420551-38-6 (compound 61) is an uncompetitive ERAP2 inhibitor. ERAP2-IN-1 specifically inhibits the ERAP2 peptide hydrolysis activity, inhibiting Arg-AMC hydrolysis with an IC50 of 27 μM and model peptide hydrolysis with an IC50 of 44 μM.	price>
R-R-0879	NR-160 Cas .2484895-50-1	NR-160 is an inhibitor of histone deacetylase 6 (HDAC6; IC50 = 0.03 µM).1 It is selective for HDAC6 over HDAC1, -2, -3, -4, and -8 (IC50s = 5.18, 2.26, 8.48, 55.4, and 14.7 µM, respectively). NR-160 is cytotoxic against a panel of seven cancer cell lines (IC50s = 22.5-51.8 µM). It enhances cytotoxicity induced by bortezomib in HL-60 cells, as well as cytotoxicity induced by epirubicin or daunorubicin in CCRF-HSB-2 T cell acute lymphoblastic leukemia cells.	price>
R-R-0888	BMSpep-57 hydrochloride	BMSpep-57 hydrochloride is a potent and competitive macrocyclic peptide inhibitor of PD-1/PD-L1 interaction with an IC50 of 7.68 nM. BMSpep-57 hydrochloride binds to PD-L1 with Kds of 19 nM and 19.88 nM in MST and SPR assays, respectively. BMSpep-57 hydrochloride facilitates T cell function by in creasing IL-2 production in PBMCs.	price>
R-R-0889	Cathepsin G Inhibitor I	Cathepsin G Inhibitor I/CAS No.429676-93-7 is a potent, selective, reversible, competitive, non-peptide inhibitor of cathepsin G.	price>

...